))
Research With Immediate Impact at 2023 SABCS
Manage episode 388383228 series 3525104
Content provided by Breastcancer.org. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Breastcancer.org or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
The 2023 San Antonio Breast Cancer Symposium featured five days of research presentations, educational sessions, and advocacy meetings.
Dr. Matthew Goetz, noted breast cancer researcher at the Mayo Clinic, explained the top research presented that will make an immediate difference for people diagnosed with breast cancer.
Listen to the podcast to hear Dr. Goetz explain:
- a study on inavolisib, a promising new treatment for advanced-stage, hormone receptor-positive breast cancer that’s stopped responded to tamoxifen or an aromatase inhibitor
- how the immunotherapy medicines Keytruda (chemical name: pembrolizumab) and Opdivo (chemical name: nivolumab) can be used to treat early-stage, triple-negative breast cancer
- overall survival results from the MONARCH-3 study on Verzenio (chemical name: abemaciclib)
- why overall survival is such an important study end point
303 episodes
Share
